ArticleGenes & genomics2026
Nrf2-dependent redox regulation protects myoblasts from polystyrene nanoplastic-induced premature senescence.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundNanoplastics (NPs) have emerged as environmental contaminants posing potential risks to human health. Recently, skeletal muscle has been recognized as a target tissue affected by NP exposure, where NPs trigger premature cellular senescence.
objectiveThis study aimed to determine whether senescence induced by polystyrene NPs (PS-NPs) in pre-differentiated C2C12 myoblasts is regulated by nuclear factor erythroid 2-related factor 2 (Nrf2), a redox-sensitive transcription factor.
methodsAfter confirming that PS-NPs induce cellular senescence in C2C12 myoblasts, we examined whether sulforaphane, an Nrf2 activator, attenuates this process by enhancing antioxidant defense and maintaining mitochondrial homeostasis. Additionally, we investigated the effects of Nrf2 knockdown on PS-NP-mediated cellular senescence.
resultsPS-NP exposure downregulated and dephosphorylated Nrf2, whereas sulforaphane treatment restored its expression and phosphorylation, concomitant with the upregulation of heme oxygenase-1 activity. Sulforaphane significantly attenuated PS-NP-induced premature cellular senescence, as evidenced by reduced β-galactosidase activity and senescence-associated marker levels and suppressed senescence-associated secretory phenotypes. Moreover, sulforaphane preserved mitochondrial integrity and decreased both intracellular and mitochondrial reactive oxygen species levels, indicating that its anti-senescence effects were mediated via activation of the Nrf2/heme oxygenase-1 pathway. Conversely, Nrf2 knockdown markedly exacerbated PS-NP-induced cellular senescence.
conclusionsOverall, these findings suggest that sulforaphane-mediated activation of Nrf2 mitigates PS-NP-induced premature myoblast senescence through redox regulation, underscoring the essential role of antioxidant defense pathways in protecting skeletal muscle cells from nanoplastic-induced cellular senescence.
Indexed as
Identifiers
41697588What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.